We expect to see more pack trade-offs in potato chips, soft drinks and cold cereal but we also see outsized pack trade-offs in coffee and granola, which implies two emerging trends in the GLP-1 population: a general decrease in snacking, even for snacks usually considered healthy, and overall collateral damage that is spreading to categories that should not be greatly affected by GLP-1 status. In addition to their impact on the retail food and beverage market, oral GLP-1 medications are expected to account for 20% of total GLP-1 drug sales by 2031, with a pill market that is estimated to grow from $3.2 billion in 2025 to $34.3 billion in 2031, according to GlobalData.
KLOW is the more relevant blend for reactive or rosacea-prone skin
Bibcode:2017Natur.546..312S
You do not need to meet Tier 2 separately
Use the reconstitution calculator and pick a volume that puts your dose in the 5-30 unit range
Bartholomae E, Knurick J, Johnston CS